Your browser doesn't support javascript.
loading
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.
Oran, Betül; Ahn, Kwang Woo; Fretham, Caitrin; Beitinjaneh, Amer; Bashey, Asad; Pawarode, Attaphol; Wirk, Baldeep; Scott, Bart L; Savani, Bipin N; Bredeson, Christopher; Weisdorf, Daniel; Marks, David I; Rizzieri, David; Copelan, Edward; Hildebrandt, Gerhard C; Hale, Gregory A; Murthy, Hemant S; Lazarus, Hillard M; Cerny, Jan; Liesveld, Jane L; Yared, Jean A; Yves-Cahn, Jean; Szer, Jeffrey; Verdonck, Leo F; Aljurf, Mahmoud; van der Poel, Marjolein; Litzow, Mark; Kalaycio, Matt; Grunwald, Michael R; Diaz, Miguel Angel; Sabloff, Mitchell; Kharfan-Dabaja, Mohamed A; Majhail, Navneet S; Farhadfar, Nosha; Reshef, Ran; Olsson, Richard F; Gale, Robert Peter; Nakamura, Ryotaro; Seo, Sachiko; Chhabra, Saurabh; Hashmi, Shahrukh; Farhan, Shatha; Ganguly, Siddhartha; Nathan, Sunita; Nishihori, Taiga; Jain, Tania; Agrawal, Vaibhav; Bacher, Ulrike; Popat, Uday; Saber, Wael.
Afiliação
  • Oran B; Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: boran@mdanderson.org.
  • Ahn KW; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Fretham C; Center for International Blood and Marrow Transplant Research, National Marrow Donor Program/Be The Match, Minneapolis, Minnesota.
  • Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami, Miami, Florida.
  • Bashey A; Division of Transplantation and Cellular Therapy, University of Miami, Miami, Florida.
  • Pawarode A; Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, Mchigan.
  • Wirk B; Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, Pennsylvania.
  • Scott BL; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Bredeson C; The Ottawa Hospital Blood and Marrow Transplant Program and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Marks DI; Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom.
  • Rizzieri D; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
  • Copelan E; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Hildebrandt GC; Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
  • Hale GA; Department of Hematology/Oncology, Johns Hopkins All Children's Hospital, St. Petersburg, Florida.
  • Murthy HS; Blood and Marrow Transplantation Program, Division of Hematology-Oncology, Mayo Clinic, Jacksonville, Florida.
  • Lazarus HM; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.
  • Cerny J; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts.
  • Liesveld JL; Department of Medicine, University of Rochester Medical Center, Rochester, New York.
  • Yared JA; Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland.
  • Yves-Cahn J; Department of Hematology, CHU Grenoble Alpes, Grenoble, France.
  • Szer J; Clinical Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Verdonck LF; Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherlands.
  • Aljurf M; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • van der Poel M; Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Litzow M; Division of Hematology and Transplant Center, Mayo Clinic, Rochester, Minnesota.
  • Kalaycio M; Hematology and Medical Oncology, Transplantation Center, Cleveland Clinic, Cleveland, Ohio.
  • Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Diaz MA; Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
  • Sabloff M; Division of Hematology, Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Kharfan-Dabaja MA; Blood and Marrow Transplantation Program, Division of Hematology-Oncology, Mayo Clinic, Jacksonville, Florida.
  • Majhail NS; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Farhadfar N; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida.
  • Reshef R; Blood and Marrow Transplantation Program and Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.
  • Olsson RF; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
  • Gale RP; Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Nakamura R; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
  • Chhabra S; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Hashmi S; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Farhan S; Henry Ford Hospital Bone Marrow Transplant Program, Henry Ford Health System, Detroit, Michigan.
  • Ganguly S; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.
  • Nathan S; Rush University Medical Center, Chicago, Illinois.
  • Nishihori T; Department of Blood & Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Jain T; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Agrawal V; Division of Hematology-Oncology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Bacher U; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Popat U; Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Saber W; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Transplant Cell Ther ; 27(11): 921.e1-921.e10, 2021 11.
Article em En | MEDLINE | ID: mdl-34403791
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article